Key result
A patient-based clinical approach coupled with cardiac magnetic resonance imaging is crucial for selecting patients for molecular genetic analysis and characterizing cardiomyopathies.
Integrating clinical evaluation with cardiac magnetic resonance is crucial for selecting patients for genetic testing and characterizing cardiomyopathies.
Answers are grounded in this paper and cite their sources.
May guide genetic testing selection in cardiomyopathies; leaves open prospective validation of this integrated approach.
In recent years, outstanding progress has been made in the diagnosis and treatment of cardiomyopathies. Genetics is emerging as a primary point in the diagnosis and management of these diseases. However, molecular genetic analyses are not yet included in routine clinical practice, mainly because of their elevated costs and execution time. A patient-based and patient-oriented clinical approach, coupled with new imaging techniques such as cardiac magnetic resonance, can be of great help in selecting patients for molecular genetic analysis and is crucial for a better characterisation of these diseases. This article will specifically address clinical, magnetic resonance and genetic aspects of the diagnosis and management of cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Sinagra et al. (2011) conducted a review in Cardiomyopathies. A patient-based clinical approach coupled with cardiac magnetic resonance imaging is crucial for selecting patients for molecular genetic analysis and characterizing cardiomyopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: